André Brizard

889 total citations
29 papers, 627 citations indexed

About

André Brizard is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, André Brizard has authored 29 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Genetics and 7 papers in Oncology. Recurrent topics in André Brizard's work include Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). André Brizard is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). André Brizard collaborates with scholars based in France, United Kingdom and Spain. André Brizard's co-authors include François Guilhot, Françoise Brizard, Nathalie Sorel, J Tanzer, Jean‐Claude Chomel, Gérard Mauco, L Christiaens, Séverine Brabant, J Allal and Stéphanie Ragot and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Journal of Cell Science.

In The Last Decade

André Brizard

28 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Brizard France 12 322 313 130 113 109 29 627
Matteo Molica Italy 16 487 1.5× 341 1.1× 77 0.6× 52 0.5× 82 0.8× 70 773
Nora P. Goette Argentina 14 334 1.0× 194 0.6× 38 0.3× 33 0.3× 62 0.6× 30 485
José María Bastida Spain 15 451 1.4× 158 0.5× 53 0.4× 56 0.5× 115 1.1× 56 677
Marianne Bach Treppendahl Denmark 16 257 0.8× 77 0.2× 52 0.4× 67 0.6× 124 1.1× 24 832
Abelardo Bárez Spain 17 513 1.6× 309 1.0× 175 1.3× 14 0.1× 156 1.4× 42 918
Ladan Duvillié France 9 385 1.2× 257 0.8× 34 0.3× 96 0.8× 11 0.1× 19 491
Carine Chaleteix France 9 256 0.8× 121 0.4× 88 0.7× 22 0.2× 64 0.6× 22 607
Gretchen LaRusch United States 9 114 0.4× 129 0.4× 24 0.2× 63 0.6× 69 0.6× 15 447
Xuebin Ji China 11 436 1.4× 97 0.3× 141 1.1× 40 0.4× 126 1.2× 20 584
Daniel Jones United States 9 64 0.2× 178 0.6× 220 1.7× 19 0.2× 63 0.6× 22 468

Countries citing papers authored by André Brizard

Since Specialization
Citations

This map shows the geographic impact of André Brizard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Brizard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Brizard more than expected).

Fields of papers citing papers by André Brizard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Brizard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Brizard. The network helps show where André Brizard may publish in the future.

Co-authorship network of co-authors of André Brizard

This figure shows the co-authorship network connecting the top 25 collaborators of André Brizard. A scholar is included among the top collaborators of André Brizard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Brizard. André Brizard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayrault, Olivier, Nathalie Sorel, Paule Seité, et al.. (2006). Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia. Leukemia Research. 30(10). 1273–1278. 2 indexed citations
2.
Millot, Frédéric, Françoise Brizard, Nathalie Sorel, et al.. (2005). Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia. Leukemia & lymphoma. 46(6). 925–927. 2 indexed citations
3.
Brizard, Françoise, et al.. (2003). p190BCR-ABL rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22). Leukemia Research. 28(1). 97–99. 18 indexed citations
4.
Sorel, Nathalie, Séverine Brabant, L Christiaens, et al.. (2003). A rapid and specific whole blood HPA‐1 phenotyping by flow cytometry using two commercialized monoclonal antibodies directed against GP IIIa and GP IIb‐IIIa complexes. British Journal of Haematology. 124(2). 221–223. 4 indexed citations
5.
Brizard, Françoise, et al.. (2003). Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML. Leukemia Research. 28(4). 345–348. 3 indexed citations
6.
Macchi, Laurent, L Christiaens, Séverine Brabant, et al.. (2003). Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms. Journal of the American College of Cardiology. 42(6). 1115–1119. 115 indexed citations
7.
Dahéron, Laurence, Françoise Brizard, Frédéric Millot, et al.. (2002). E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype. The Hematology Journal. 3(3). 153–156. 4 indexed citations
8.
9.
Lacombe, Corinne, et al.. (1999). Heterogeneity of Serum IgG Subclass Deficiencies in B Chronic Lymphocytic Leukemia. Clinical Immunology. 90(1). 128–132. 22 indexed citations
10.
Brizard, Françoise, et al.. (1999). Aml1/ETO and Pml/RARA Rearrangements in a Case of AML-M2 Acute Myeloblastic Leukemia with t(15;17). Leukemia & lymphoma. 33(3-4). 403–406. 8 indexed citations
11.
Garand, Richard, André Brizard, Jacqueline Buisine, et al.. (1998). Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia. British Journal of Haematology. 103(2). 488–494. 95 indexed citations
12.
Beau, Philippe, et al.. (1997). Comparison of Bone Marrow Toxicity of Medium‐Chain and Long‐Chain Triglyceride Emulsions: An In Vitro Study in Humans. Journal of Parenteral and Enteral Nutrition. 21(6). 343–346. 2 indexed citations
13.
Brizard, Françoise, Brigitte Dreyfus, François Guilhot, J Tanzer, & André Brizard. (1997). 11q13 Rearrangement in B Cell Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 25(5-6). 539–543. 5 indexed citations
14.
Brizard, André, et al.. (1996). Mastocytoses systémiques associées à un syndrome myélodysplasique. Hématologie. 2(6). 1 indexed citations
15.
Mahon, François‐Xavier, Françis Belloc, D. Cowen, et al.. (1995). Specific Antisense Oligomer Anti Bcr-abl Junctions in Chronic Myeloid Leukemia: A Cell Cycle Analysis and CFU-GM Study. Leukemia & lymphoma. 19(5-6). 423–429. 3 indexed citations
16.
Brizard, André, Jean‐Loup Huret, Françoise Brizard, et al.. (1994). Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T‐prolymphocytic leukaemia: four new cases and a review of the literature. British Journal of Haematology. 86(4). 780–785. 30 indexed citations
17.
Cogné, Michel, et al.. (1993). Complete variable region deletion in Aα heavy chain disease protein (roul). Correlation with light chain secretion. Leukemia Research. 17(6). 527–532. 8 indexed citations
18.
20.
Brizard, André, et al.. (1990). Translocation (8;9)(q12;p21). Cancer Genetics and Cytogenetics. 45(1). 125–129. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026